An Unusual Case of Cholestatic Hepatitis due to Light-Chain Deposition Disease

被引:4
作者
Grembiale, Alessandro [1 ]
Garlatti, Elena [1 ]
Ermacora, Anna [1 ]
Grazioli, Silvia [1 ]
Balbi, Massimiliano [2 ]
Tonizzo, Maurizio [1 ]
机构
[1] ASFO Pordenone, Dept Internal Med, Via Montereale 24, IT-33170 Pordenone, Italy
[2] ASFO San Vito Al Tagliamento PN, Dept Internal Med, San Vito Al Tagliamento, Italy
关键词
Light-chain deposition disease; Monoclonal light chains; Amyloidosis; Cholestatic hepatitis; Bortezomib; LIVER INVOLVEMENT; RENAL INVOLVEMENT; PATIENT; BORTEZOMIB; FAILURE;
D O I
10.1159/000509508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Light-chain deposition disease (LCDD) is a rare paraproteinaemia characterized by the deposition of monoclonal immunoglobulins with a non-fibrillar structure and hence Congo red negative deposits. Kidney disease is the more frequent manifestation, but other organs may also be involved. A 70-year-old man with hypertension and mild chronic renal failure showed a hepatomegaly without splenomegaly. His renal and liver test rapidly got worse. A serum electrophoresis and immunofixation isolated monoclonal kappa light-chain gammopathy, with serum free kappa light chain excess. The bone marrow biopsy showed the presence of interstitial infiltration of plasma cells like multiple myeloma type at initial phase. Periumbilical fat biopsy was negative. Echocardiography demonstrated an infiltrative cardiac disease. The biopsies of the duodenum small intestine mucosa showed flaps with eosinophil material (Masson's staining) with atrophic crypts and chronic inflammation at chorion level. Amyloid substance was negative. There was a strong positivity for light chains kappa compatible with LCDD. A liver biopsy confirmed this finding. Therapy with dexamethasone and bortezomib improved clinical state and hepatic and renal laboratory tests. Chemotherapy based on novel anti-myeloma agents should be rapidly considered in LCDD patients with severe organ involvement.
引用
收藏
页码:1343 / 1348
页数:6
相关论文
共 15 条
[1]   MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE - LIGHT CHAIN AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASES AND THEIR RELATION TO LIGHT CHAIN AMYLOIDOSIS - CLINICAL-FEATURES, IMMUNOPATHOLOGY, AND MOLECULAR ANALYSIS [J].
BUXBAUM, JN ;
CHUBA, JV ;
HELLMAN, GC ;
SOLOMON, A ;
GALLO, GR .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :455-464
[2]   Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease [J].
Cohen, Camille ;
Royer, Bruno ;
Javaugue, Vincent ;
Szalat, Raphael ;
El Karoui, Khalil ;
Caulier, Alexis ;
Knebelmann, Bertrand ;
Jaccard, Arnaud ;
Chevret, Sylvie ;
Touchard, Guy ;
Fermand, Jean-Paul ;
Arnulf, Bertrand ;
Bridoux, Frank .
KIDNEY INTERNATIONAL, 2015, 88 (05) :1135-1143
[3]  
DROZ D, 1984, LAB INVEST, V50, P683
[4]   κ light chain deposition disease of the liver [J].
Girelli, CM ;
Lodi, G ;
Rocca, F .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (05) :429-430
[5]   Light chain deposition disease: novel biological insights and treatment advances [J].
Jimenez-Zepeda, V. H. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (04) :347-355
[6]   Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant [J].
Leung, Nelson ;
Bridoux, Frank ;
Hutchison, Colin A. ;
Nasr, Samih H. ;
Cockwell, Paul ;
Fermand, Jean-Paul ;
Dispenzieri, Angela ;
Song, Kevin W. ;
Kyle, Robert A. .
BLOOD, 2012, 120 (22) :4292-4295
[7]   Liver Failure Caused by Light Chain Deposition Disease Associated with Multiple Myeloma [J].
Mena-Duran, Armando ;
Munoz Vicente, Elia ;
Pareja Llorens, Gonzalo ;
Sanchis Cervera, Jose .
INTERNAL MEDICINE, 2012, 51 (07) :773-776
[8]   Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome [J].
Michopoulos, S ;
Petraki, K ;
Petraki, C ;
Dimopoulos, MA .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (04) :730-734
[9]   A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis [J].
Palladini, Giovanni ;
Sachchithanantham, Sajitha ;
Milani, Paolo ;
Gillmore, Julian ;
Foli, Andrea ;
Lachmann, Helen ;
Basset, Marco ;
Hawkins, Philip ;
Merlini, Giampaolo ;
Wechalekar, Ashutosh D. .
BLOOD, 2015, 126 (05) :612-615
[10]   Light chain deposition disease with renal involvement: Clinical characteristics and prognostic factors [J].
Pozzi, C ;
D'Amico, M ;
Fogazzi, GB ;
Curioni, S ;
Ferrario, F ;
Pasquali, S ;
Quattrocchio, G ;
Rollino, C ;
Segagni, S ;
Locatelli, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (06) :1154-1163